| Estrone | IC50 | 109.0 [1], 218.0 [2], 330.0 [3], 600.0 [4], 810.0 [5] |
| Estrone | Ki | 3.0 [1], 9500.0 [2] |
| 6-(3-Hydroxyphenyl)-2-naphthol | IC50 | 116.0 [1], 229.0 [2] |
| O5'-[9-(3,17B-Dihydroxy-1,3,5(10)-estratrien-16B-YL)-nonanoyl]adenosine | IC50 | 8.0 [1], 52.0 [2] |
| O5'-[9-(3,17B-Dihydroxy-1,3,5(10)-estratrien-16B-YL)-nonanoyl]adenosine | Ki | 3.0 [1] |
| 6-(3-Hydroxyphenyl)-1-phenyl-2-naphthol | IC50 | 20.0 [1], 281.0 [2] |
| 3-{[(9beta,14beta,16alpha,17alpha)-3,17-Dihydroxyestra-1,3,5(10)-trien-16-yl]methyl}benzamide | IC50 | 27.0 [1], 44.0 [2] |
| 6-(4-Hydroxyphenyl)-1-naphthol | IC50 | 2425.0 [1] |
| 3,3'-Thiene-2,5-diyldiphenol | IC50 | 173.0 [1] |
| 3-[5-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol | IC50 | 310.0 [1], 380.0 [2] |
| (3-Hydroxyphenyl)(5-(3-hydroxyphenyl)thiophen-2-yl)methanone | IC50 | 22.0 [1], 69.0 [2] |
| 5-(2-Fluoro-3-methoxyphenyl)-N-[(3-hydroxyphenyl)methyl]-N-methylthiophene-2-carboxamide | IC50 | 4452.0 [1] |
| 3-(4-Hydroxyphenyl)-N-[(3-hydroxyphenyl)methyl]-N-methylbenzamide | IC50 | 3801.0 [1], 9099.0 [2] |
| 5-(3-Hydroxyphenyl)-N-[(3-hydroxyphenyl)methyl]-N-methylthiophene-2-carboxamide | IC50 | 5449.0 [1] |
| CID 60196493 | IC50 | 6728.0 [1], 7593.0 [2] |
| N-(3-Methoxyphenyl)-N-methyl-5-(3-methylphenyl)thiophene-2-carboxamide | IC50 | 6752.0 [1], 7616.0 [2] |
| (2,6-Difluoro-3-hydroxyphenyl)-[5-(4-hydroxyphenyl)thiophen-2-yl]methanone | IC50 | 3.0 [1], 3.1 [2], 7.9 [3] |
| [5-(4-Hydroxy-3-methylphenyl)-2-thienyl](3-hydroxyphenyl)-methanone | IC50 | 8.0 [1], 27.0 [2] |
| 3-[[(8R,9S,13S,14S,16R,17S)-3-(2-Bromoethyl)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]methyl]benzamide | IC50 | 68.0 [1], 97.0 [2] |
| (6-Hydroxy-1,3-benzothiazol-2-yl)-(3-hydroxy-4-methylphenyl)methanone | IC50 | 27.0 [1], 258.0 [2] |
| (4-Fluoro-3-hydroxyphenyl)-(6-hydroxy-1,3-benzothiazol-2-yl)methanone | IC50 | 11.0 [1], 13.0 [2] |
| 3-Cyano-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 21.0 [1], 30.0 [2], 402.0 [3] |
| 6-(3-Hydroxyphenyl)-1-(6-methoxypyridin-3-yl)naphthalen-2-ol | IC50 | 33.0 [1], 670.0 [2], 840.0 [3] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]methanesulfonamide | IC50 | 15.0 [1], 23.0 [2], 71.0 [3] |
| 3-Chloro-2-methyl-N-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide | IC50 | 3341.0 [1], 10000.0 [2] |
| 2-(2-(3-Chloro-2-methylphenylsulfonamido)thiazol-4-yl)-N,N-diethylacetamide | IC50 | 52.0 [1], 10000.0 [2] |
| 3-(4-Fluorophenyl)-5-[4-[4-methyl-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazol-3-yl]-1-bicyclo[2.2.2]octanyl]-1,2,4-oxadiazole | IC50 | 2.2 [1], 1000.0 [2] |
| 2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol | IC50 | 8.0 [1] |
| 5-(3-Methoxyphenyl)-N-[(3-methoxyphenyl)methyl]-N-methylthiophene-2-carboxamide | IC50 | 10000.0 [1], 100000.0 [2] |
| 2-[(8R,9S,13S,14S)-3-Hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(pyridin-3-ylmethyl)acetamide | IC50 | 37.0 [1] |
| 2-[(8R,9S,13S,14S,16R)-2-Ethyl-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(pyridin-3-ylmethyl)acetamide | IC50 | 27.0 [1] |
| [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 11-[(8R,9S,13S,14S,16R,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]undecanoate | IC50 | 310.0 [1] |
| [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 10-[(8R,9S,13S,14S,16S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]decanoate | IC50 | 140.0 [1] |
| [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 8-[(8R,9S,13S,14S,16S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]octanoate | IC50 | 93.0 [1] |
| [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 7-[(8R,9S,13S,14S,16S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]heptanoate | IC50 | 430.0 [1] |
| [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 11-[(8R,9S,13S,14S,16S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]undecanoate | IC50 | 120.0 [1] |
| [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 12-[(8R,9S,13S,14S,16S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]dodecanoate | IC50 | 1000.0 [1] |
| [5-(2,4-Difluorophenyl)thiophen-2-yl]-(2,4,5-trifluoro-3-hydroxyphenyl)methanone | IC50 | 7.0 [1], 7.2 [2] |
| [5-(2,4-Difluorophenyl)thiophen-2-yl]-(3-hydroxy-2-methylphenyl)methanone | IC50 | 3400.0 [1], 3427.0 [2] |
| [6-(4-Hydroxy-3-methylphenyl)pyridin-2-yl]-(3-hydroxyphenyl)methanone | IC50 | 19646.0 [1], 19650.0 [2] |
| 3-[4-(3-Hydroxyphenyl)phenyl]phenol | IC50 | 173.0 [1] |
| 4-[2-(3-Hydroxyphenyl)-1,3-thiazol-5-yl]phenol | IC50 | 50.0 [1] |
| 3-(5-Phenylthiophen-2-yl)phenol | IC50 | 342.0 [1] |
| 3-[5-(4-Hydroxyphenyl)-2-thienyl]phenol | IC50 | 69.0 [1] |
| 3-[4-(4-Hydroxyphenyl)-2-thienyl]phenol | IC50 | 77.0 [1] |
| 3-[4-(4-Hydroxyphenyl)phenyl]phenol | IC50 | 471.0 [1] |
| (13S,16Z)-3-Hydroxy-16-(hydroxymethylidene)-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-one | IC50 | 110.0 [1] |
| (9S)-9-Methyl-6,7-diazapentacyclo[10.8.0.02,9.04,8.013,18]icosa-4(8),5,13(18),14,16-pentaen-16-ol | IC50 | 180.0 [1] |
| (4-Fluoro-3-hydroxyphenyl)(5-(4-hydroxyphenyl)thiophen-2-yl)methanone | IC50 | 21.0 [1] |
| 4-(3-Methoxyphenyl)-N-[(3-methoxyphenyl)methyl]-N-methylbenzamide | IC50 | 100000.0 [1] |
| 4-(3-Hydroxyphenyl)-N-[(3-hydroxyphenyl)methyl]-N-methylbenzamide | IC50 | 13009.0 [1] |
| (4-Fluoro-3-hydroxyphenyl)-[4-(4-hydroxy-3-methylphenyl)phenyl]methanone | IC50 | 289.0 [1], 290.0 [2] |
| [5-(4-Hydroxy-3-methylphenyl)pyridin-2-yl]-(3-hydroxyphenyl)methanone | IC50 | 5480.0 [1], 5482.0 [2] |
| (4-Fluoro-3-hydroxyphenyl)-[5-(4-hydroxy-3-methylphenyl)pyridin-2-yl]methanone | IC50 | 1270.0 [1], 1272.0 [2] |
| CID 60196908 | IC50 | 4821.0 [1] |
| CID 60196910 | IC50 | 18663.0 [1] |
| 16-Oximinoestrone | IC50 | 1100.0 [1] |
| 3-[[(8R,9S,13S,14S,16R,17S)-3-(Bromomethyl)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]methyl]benzamide | IC50 | 430.0 [1] |
| 6-(3-Hydroxyphenyl)-1-(pyridin-4-yl)-2-naphthol | IC50 | 39.0 [1], 64.0 [2] |
| (2,5-Dihydroxyphenyl)-(6-hydroxy-1,3-benzothiazol-2-yl)methanone | IC50 | 78.0 [1], 365.0 [2] |
| [2-(4-Hydroxy-3-methylphenyl)-1,3-thiazol-5-yl](3-hydroxyphenyl)methanone | IC50 | 35.0 [1], 107.0 [2] |
| [3-Chloro-4-[5-(2,6-difluoro-3-hydroxybenzoyl)thiophen-2-yl]phenyl] sulfamate | IC50 | 10.2 [1], 60.9 [2] |
| [2-Chloro-4-[5-(2,6-difluoro-3-hydroxybenzoyl)thiophen-2-yl]phenyl] sulfamate | IC50 | 1.1 [1], 22.2 [2] |
| [4-[5-(2,6-Difluoro-3-hydroxybenzoyl)thiophen-2-yl]-3-fluorophenyl] sulfamate | IC50 | 12.2 [1], 42.1 [2] |
| [4-[5-(2,6-Difluoro-3-hydroxybenzoyl)thiophen-2-yl]-2-fluorophenyl] sulfamate | IC50 | 2.5 [1], 20.0 [2] |
| 6-(3-Hydroxyphenyl)-1-(pyridin-3-yl)-2-naphthol | IC50 | 26.0 [1], 165.0 [2] |
| 1,6-Bis(3-hydroxyphenyl)-2-naphthol | IC50 | 36.0 [1], 115.0 [2] |
| 2-Cyano-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 14.0 [1], 157.0 [2] |
| N-[4-[[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]sulfamoyl]phenyl]acetamide | IC50 | 12.0 [1], 240.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-4-nitrobenzenesulfonamide | IC50 | 49.0 [1], 753.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]thiophene-2-sulfonamide | IC50 | 28.0 [1], 316.0 [2] |
| 4-Bromo-2,5-difluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 46.0 [1], 646.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-3-nitrobenzenesulfonamide | IC50 | 20.0 [1], 396.0 [2] |
| (3-Hydroxyphenyl)(5-(4-hydroxyphenyl)thiophen-2-yl)methanone | IC50 | 30.0 [1], 33.0 [2] |
| [5-(3-Fluoro-4-hydroxyphenyl)-2-thienyl](3-hydroxyphenyl)-methanone | IC50 | 17.0 [1], 19.0 [2] |
| [5-(3-Chloro-4-hydroxyphenyl)-2-thienyl](3-hydroxyphenyl)-methanone | IC50 | 5.0 [1], 126.0 [2] |
| [5-(3-Ethyl-4-hydroxyphenyl)-2-thienyl](3-hydroxyphenyl)-methanone | IC50 | 20.0 [1], 367.0 [2] |
| 2,6-Difluoro-3-hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide | IC50 | 13.0 [1], 37.0 [2] |
| 2-Fluoro-5-hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide | IC50 | 112.0 [1], 152.0 [2] |
| 3-Hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide | IC50 | 243.0 [1], 245.0 [2] |
| 2-Fluoro-3-hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide | IC50 | 29.0 [1], 73.0 [2] |
| 2-Fluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 29.0 [1], 429.0 [2] |
| 3-Fluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 22.0 [1], 462.0 [2] |
| 4-Fluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 53.0 [1], 637.0 [2] |
| 3-Hydroxy-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 14.0 [1], 701.0 [2] |
| 4-Hydroxy-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 19.0 [1], 1009.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-2-methylbenzenesulfonamide | IC50 | 31.0 [1], 525.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-3-methylbenzenesulfonamide | IC50 | 33.0 [1], 440.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-4-methylbenzenesulfonamide | IC50 | 35.0 [1], 633.0 [2] |
| 2,2,2-Trifluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]ethanesulfonamide | IC50 | 32.0 [1], 246.0 [2] |
| 1-[1-(Benzenesulfonyl)indol-4-yl]-6-(3-hydroxyphenyl)naphthalen-2-ol | IC50 | 32.0 [1], 1100.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]quinoline-6-sulfonamide | IC50 | 92.0 [1], 498.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 15.0 [1], 196.0 [2] |
| N-[3-[2-Hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-2-nitrobenzenesulfonamide | IC50 | 17.0 [1], 462.0 [2] |
| 4-Cyano-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide | IC50 | 25.0 [1], 555.0 [2] |
| Genistein | IC50 | 2210.0 [1] |
| Apigenin | IC50 | 710.0 [1] |
| Kaempferol | IC50 | 1050.0 [1] |
| Naringenin | IC50 | 4960.0 [1] |
| Endosulfan | IC50 | 48250.0 [1] |